Barry Jones, Ph.D. | November 16, 2017

Small Molecule Biomarker Assay Validation Strategies Using Surrogate Matrix and Surrogate Analyte Approaches

Complex Challenges Call for Two Unique Biomarker Methods
In this scientific presentation, learn about the complex challenges of small molecule biomarker quantitation, plus two main approaches that are used to overcome these challenges. Each approach also features a key case study from our scientific expert.

We are one of the few bioanalytical laboratories successfully employing immunoprecipitation techniques and multi-dimensional Liquid chromatography for the quantitation of biotherapeutics, peptides, proteins, and biomarkers. Our scientists have extensive expertise in bioanalytical testing, method development and Liquid chromatography – tandem mass spectrometry to not only meet customers’ analytical needs but to bring insights to the table that enhance the drug development process. 

Download the presentation to learn more.

Barry Jones, Ph.D., Associate Director, LCMS Biologics and Biomarkers

Related Services:
Bioanalytical & ADME Laboratory Services

Accelerate and enhance your discovery, preclinical and clinical programs

Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Fit for Purpose Development and Validation of a Urea Biomarker Assay to Support Pre-Clinical Studies

Finding a suitable assay for measuring urea levels during human clinical trials

Read More